lunes, 13 de julio de 2020

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO - STAT

Relay Therapeutics, focused on solid tumors, seeks to raise $250M in IPO - STAT

The Readout

Damian Garde & Meghana Keshavan

More reads

  • Relay Therapeutics, focused on solid tumors, seeks to raise $250 million in an IPO. (Boston Globe)
  • Boehringer Ingelheim-backed COVID researchers identify new antibodies to fight the virus. (FierceBiotech)

No hay comentarios: